0001333280-24-000006.txt : 20240308 0001333280-24-000006.hdr.sgml : 20240308 20240308171443 ACCESSION NUMBER: 0001333280-24-000006 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240306 FILED AS OF DATE: 20240308 DATE AS OF CHANGE: 20240308 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Conder Keenan Michael CENTRAL INDEX KEY: 0001333280 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40531 FILM NUMBER: 24735539 MAIL ADDRESS: STREET 1: C/O TABLEAU SOFTWARE, INC. STREET 2: 837 N. 34TH ST., SUITE 200 CITY: SEATTLE STATE: WA ZIP: 98103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SentinelOne, Inc. CENTRAL INDEX KEY: 0001583708 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] ORGANIZATION NAME: 06 Technology IRS NUMBER: 990385461 STATE OF INCORPORATION: DE FISCAL YEAR END: 0131 BUSINESS ADDRESS: STREET 1: 444 CASTRO STREET STREET 2: SUITE 400 CITY: MOUNTAIN VIEW STATE: CA ZIP: 94041 BUSINESS PHONE: 855-868-3733 MAIL ADDRESS: STREET 1: 444 CASTRO STREET STREET 2: SUITE 400 CITY: MOUNTAIN VIEW STATE: CA ZIP: 94041 FORMER COMPANY: FORMER CONFORMED NAME: Sentinel Labs, Inc. DATE OF NAME CHANGE: 20210405 FORMER COMPANY: FORMER CONFORMED NAME: SentinelOne, Inc. DATE OF NAME CHANGE: 20210402 FORMER COMPANY: FORMER CONFORMED NAME: Sentinel Labs, Inc. DATE OF NAME CHANGE: 20130805 4 1 wk-form4_1709936069.xml FORM 4 X0508 4 2024-03-06 0 0001583708 SentinelOne, Inc. S 0001333280 Conder Keenan Michael C/O SENTINELONE, INC. 444 CASTRO STREET, SUITE 400 MOUNTAIN VIEW CA 94041 0 1 0 0 Chief Legal Officer & Sec'y 0 Class A Common Stock 2024-03-06 4 S 0 5157 27.25 D 462240 D The sale reported on this Form 4 represents an Issuer mandated sale by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units, and it does not represent a discretionary trade by the Reporting Person. Pursuant to the Issuer's equity incentive plan, an award recipient's tax withholding obligations must be funded by a "sell to cover" transaction. Certain of the shares are subject to forfeiture to the Issuer if underlying vesting conditions are not met. /s/ David J. Bernhardt - Attorney-in-Fact 2024-03-08